Episode 420 -- DOJ Announces New West Coast Health Care Fraud Strike Force
Hospice Insights Podcast - Bottom Line, Top of Mind: Compliance Checklists for Hospice and Home Health
Health-e Law Podcast, Episode 26 Pt. 1 | AI Adoption in Healthcare: Managing Data Privacy, Vendor Relationships and Governance
False Claims Act Insights - Managed Care FCA Enforcement: Risk Adjustment, AI, Kickbacks, and More
Podcast — Drug Pricing and Market Access: CMS Update With Rujul Desai
Podcast — Drug Pricing and Market Access: Highlights From Recent CMS and AHLA Conferences
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 277: M&A Trends and Growth in the Life Sciences Industry with John Erwin of Maynard Nexsen
Patients Recording Medical Visits: What Health Care Providers Need to Know
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 276: Educating the Life Sciences Workforce with Wake Tech’s Leslie Isenhour
Podcast - The New Rules of Healthcare Fraud Enforcement
Hospice Insights Podcast - Hospice Audit Updates: UPICs May Pick You for a Prepayment Review
Strategic Alignment With Collaboration Is Essential to a Life Sciences M&A Exit — Troutman Pepper Locke Podcast
AI's Hidden Power Grid: Data Centers, Subsea Cables, and the New Infrastructure Arms Race — The Good Bot: Artificial Intelligence, Health Care, and the Law
Charting a Course for Collections: Diagnosing Compliance and Privacy Risks in Medical Debt — The Consumer Finance Podcast
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 275: Strategies for Building the Life Sciences Talent Pipeline with NIIMBL’s John Balchunas
Health+Tech - Healthcare Private Equity Conference Recap
Health+Tech - From Software to Scrutiny: Navigating FDA Inspections Under the New QMSR
Health+Tech - The Perfect Storm: Cyber Threats, Regulation and AI in Healthcare
Podcast - Inside Telehealth's Growth, Regulation and Access
Health-e Law Podcast, Episode 25 | Human-in-the-Loop: Bringing AI to Skilled Nursing Facilities
Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24-889 - Introduction - Yesterday, the Supreme Court held in a unanimous 9-0 decision that induced patent infringement requires active steps to encourage...more
Key Takeaways - On June 1, CMS released an interim final rule implementing the new Medicaid community engagement requirement (i.e., work requirement) as a condition of Medicaid eligibility for adults aged 19-64 with access to...more
Since Governor Newsom signed AB 1415 into law last October, stakeholders have been awaiting the release of draft regulations from California’s Office of Health Care Affordability (“OHCA”) to clarify the statute’s notice and...more
Following a trend among federal agencies to crack down on alleged fraud in taxpayer-funded federal programs, the Department of Justice ("DOJ") Civil Division announced reforms that aim to leverage a whole-of-government...more
A unanimous Supreme Court reversed the Federal Circuit and held that Amarin did not plausibly allege that Hikma’s skinny label and marketing actively induced infringement of Vascepa’s cardiovascular-use patents — a decisive...more
As part of a coordinated national and state effort to address alleged Medicaid fraud in Ohio, the Ohio Department of Medicaid (ODM) has immediately suspended payments for Ohio Medicaid home health and waiver services provided...more
As noted in last week’s Regs & Eggs blog post, the Centers for Medicare & Medicaid Services (CMS) is in the process of laying out a feast of Medicaid regs....more
This issue of McDermott Will & Schulte’s Healthcare Regulatory Check-Up highlights regulatory activity for April 2026, including recent enforcement actions involving the False Claims Act (FCA), two favorable Office of...more
Between 2025 and 2026, several proposed changes to New York’s lead regulations have emerged at both the state and city levels. One of the most significant is Bill S122A, introduced last year, which directs the New York State...more
Former Congressman Peter Roskam, who leads BakerHostetler’s Federal Policy team, provides listeners with a front-row seat to the most important policy and political debates in Congress. In this episode of “The Cloakroom with...more
Key Takeaways: Ohio Boards are increasing enforcement against nurses involved in IV therapy and aesthetic injections....more
On June 4, 2026, the U.S. Supreme Court held in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24-889, that routine generic drug marketing activities, including skinny labels, standard therapeutic equivalence...more
On May 29, 2026, Boan Biotech announced that it submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for BA6101 (denosumab; injection 60 mg) and BA1102 (denosumab; injection 120 mg),...more
Bregal Sagemount has made a strategic growth investment in LSPedia, according to a news release. LSPedia, founded in 2013 and with its U.S. headquarters in Farmington Hills, Michigan, is a provider of compliance,...more
Many families believe they are 'covered' once a Power of Attorney (POA) is executed. It is one of the most practical documents in any estate plan, allowing a trusted person to step in and manage finances when you cannot....more
On May 27, 2026, the Department of Justice (DOJ) announced a False Claims Act settlement with psychiatric hospital operator Oglethorpe Inc. (Oglethorpe) and three executives resolving allegations that they violated the False...more
In a unanimous decision handed down today, the Supreme Court delivered a tactical victory for Hikma, and a measure of guidance for other generic manufacturers. In Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No....more
Today, the U.S. Supreme Court issued its decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24-889, unanimously reversing the Federal Circuit and holding that Amarin failed to state a claim “more than a...more
On May 27, 2026, DOJ’s Civil Division announced (“Announcement”) new efforts included in the Shumate Memo to accelerate the review of FCA whistleblower complaints alleging fraud against federally funded, state-administered...more
Key Takeaways: New mandatory work requirements take effect July 31, 2026. CMS has published an Interim Final Rule implementing the requirement in H.R. 1 that certain Medicaid beneficiaries who live in states that expanded...more
In January 2026, Holland & Knight's Healthcare Blog summarized several notable healthcare-related proposals in New York Gov. Kathy Hochul's fiscal year (FY) 2026-27 Executive Budget. These included expanded oversight of...more
Key Takeaways: Congress is considering expanded Schedule H reporting requirements for certain tax-exempt hospital organizations required to file Form 990 to require more detail on community benefit, charity care, 340B...more
Massachusetts AG Andrea Joy Campbell sued UnitedHealthcare Insurance Company, d/b/a UnitedHealthcare Community Plans of Massachusetts, asserting Massachusetts False Claims Act, unjust enrichment, and breach of contract claims...more
On May 28, the U.S. Department of Health and Human Services (HHS) finalized regulations intended to make the Independent Dispute Resolution (IDR) process under the No Surprises Act (NSA) more efficient and transparent in...more
Personalized medicine continues to reshape life sciences innovation, but it also introduces unique challenges in today’s evolving legal landscape....more
